Guardant Health $83M Appeal After Patent Verdict
Silicon Valley cancer diagnostics trailblazer, Guardant Health, is gearing up for an intense legal tussle as it appeals an adverse $83.4 million verdict handed down a day earlier in a high-stakes patent battle against a Seattle-based rival. Unanimous Blow in Wilmington, Delaware The seismic verdict, delivered in Wilmington, Delaware on Tuesday, concluded a gripping five-day
Source: usaherald.com
